Over the past week, European healthcare companies have been at the forefront of raising early-stage capital. In the Netherlands, Salvia BioElectronics has raised €26m (US$31m) to develop innovative neurostimulation therapy…
Over the past week, European healthcare companies have been at the forefront of raising early-stage capital. In the Netherlands, Salvia BioElectronics has raised €26m (US$31m) to develop innovative neurostimulation therapy…
…
Rankings & Reports
M&A
Equity
Healthcare Investing Review
Healthcare Real Assets Report
Resources & Events
Resource Hub
Sector Events
Private Capital Conference
Real Assets Conference